| Long name: |
Thrombin Activation peptide fragment 1 Antibody |
| Also known as: |
Thrombin Activation peptide fragment 1 Antibody |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
Thrombin Activation peptide fragment 1 |
| Specificity: |
This is a highly specific antibody against Thrombin Activation peptide fragment 1 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human Thrombin Activation peptide fragment 1 |
| Gene ID number: |
2147 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Glycosaminoglycan binding to exosite II of thrombin plays a major role in switching off the procoagulant functions of thrombin by mediating its irreversible inhibition by circulating serpins and by its binding to the endothelial cell surface receptor thrombomodulin, The ability of thrombin to specifically recognize a wide range of substrates derives from interactions which occur outside of the active site of thrombin, Thrombin possesses two anion binding exosites which mediate many of its interactions with cofactors and substrates, and although many structures of thrombin have been solved, few such interactions have been described in molecular detail, Thrombin is the final protease in the blood coagulation cascade and serves both pro- and anticoagulant functions through the cleavage of several targets |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
Cf-2, Cf2, Coagulation factor II, Coagulation factor II precursor, F 2, F2, F2, FII, Factor II, Factor-II, PT, Prothrombin, THRB, THRB_HUMAN, Thrombin, coagulation factor II, coagulation factor II thrombin, prothrombin, prothrombin B-chain, serine protease, Activation peptide fragment 1 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Description: |
, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, consisting of 2 amino acids joined by a single peptide bond, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, Peptides short amino acid chains or epitopes or blocking antagonists |
| Gene target: |
Thrombin Activation peptide 1 |
| Short name: |
Thrombin Activation peptide 1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, peptides, Antibody |
| Isotype: |
Complement fragments, Fragment peptides for polyclonals give monoclonal like antibodies as the epitope is very small, IgG Fc and(ab)2 fragments are small and stable subunits of the antibody obtained by enzymatic digestion, bp DNA fragments are common, coli expressed, single chain variable fragments can be E, Antibody fragments and scFv fragments |
| Alternative name: |
Thrombin Activation short protein sequence fragment 1 (Antibody to) |
| Alternative technique: |
antibodies |